Wow! New Drug for Adrenal Insufficiency

Plenadren. Plenadren. I hope this word becomes so familiar to me that it easily rolls off my tongue.

Plenadren is the new, once-a-day, hydrocortisone modified-release tablets that researchers in Denmark believe will work better for patients who face adrenal insufficiency. The patients fight Addison's, cyclical Cushing's, as well as Cushing's post-op. 

This is very big news.

http://cushingsmoxie.blogspot.com

• ViroPharma launches Plenadren for rare endocrine disorder

• September 21, 2012
 
• | Kevin Grogan, Pharma Times

ViroPharma has begun the roll-out in Europe of Plenadren, which it says is "the first true innovation in over 50 years in the treatment of adrenal insufficiency".

The firm has launched Plenadren (hydrocortisone modified-release tablets) in Denmark, after it was approved by the European Commission in November 2011. The once-daily pill is designed to better mimic the body's normal, cortisol profile, compared with standard glucocorticoid treatment.

Plenadren proved to be effective and well-tolerated in a Phase II/III trial compared to standard therapy, also avoiding the unphysiological cortisol peaks seen with the latter. ViroPharma noted that these peaks are thought to be associated with an increased risk of morbidity and premature mortality.

Anna Nilsson of the Sahlgrenska University Hospital in Gothenburg, Sweden and principal investigator for all Plenadren studies, said "there is a clear need in the treatment of AI for an oral hydrocortisone replacement therapy that better resembles the body's natural cortisol production, that can be given once a day and that may improve patients' metabolic status and compliance to treatment". She added that "a new therapeutic option for the first time in 50 years, that appears to achieve this is exciting news".

AI is a rare, chronic and potentially fatal endocrine disorder that affects less than 4.5 in 10,000 people in Europe.

Click here for PharmaTimes article.

Fiddling with Nature Causes Tumors

Genetically-engineered food:  another environmental cause of pituitary tumors.And doctors still have the nerve to call us fat, tell us to exercise, and dismiss our symptoms systematically?!

GE Foods Shorten Life, Cause Tumors, Says First-Ever Long-Term Study

"The researchers found that rats fed GE corn and those whose water contained environmentally relevant levels of RoundUp faced the following:

·  Two to three times more large tumors than the control group;

·  The females developed mammary and pituitary gland tumors, and suffered pituitary gland abnormalities and hormone disruption;

·  Male rats also developed tumors, but in particular experienced serious kidney and liver damage;

·  50 percent of males and 70 percent of females died prematurely, compared to 30 percent and 20 percent, respectively, in the control groups."You can read about the study here.

Many other countries have banned substances that our own FDA still allows.  I wrote about throwing out all our cookware here and buying stuff we could barely afford here:  Why Cushing's May Not Be As Be As Rare As They Thought: Check your Cookware and Your Chemical Neighbors

Courageous Cushies

For Lori and all of us Cushies, who wake up every morning and try to live a full life.

(Thanks to my friend Meagan for sharing.)

My friend Lori faces 5th pituitary surgery

Please keep Lori in your thoughts. Her cortisol levels dramatically improved/ dropped following Monday's operation in which the neurosurgeon removed two separate tumors. However, the lab work indicates there is still tumor tissue present. She will be having another pituitary surgery -- her 5th in an area the size of a pea-- tomorrow at 7 am central time. The neurosurgeon will remove her entire pituitary gland and the bone surrounding it. This is a much more invasive surgery.

Lori has been fighting for too long to give up now. This surgery is her only option. She first went to the National Institute of Health, long recognized as the most knowledgeable about this disease, when she was only 13. Twenty years later, she is still fighting Cushing's. For many of us, Cushing's won't turn loose. This time, it will.

http://cushingsmoxie.blogspot.com/2012/09/a-case-of-ectopic-pituitary-adenoma.html?m=1

My Friend Lori, a Cushie Warrior, Faces 4th Pituitary Surgery

A friend with persistent Cushing's had her fourth pituitary surgery this past Monday. The neurosurgeon found an 8-9 mm tumor in her sinus cavity that was definitely a Cushing's tumor. This trouble spot had a tail of tissue trailing back to her pituitary to a small spot of abnormal cells.

The neurosurgeon believes that just a few microscopic cells fell during her first pituitary surgery and started a growth of abnormal ACTH cells that caused her Cushing's. The patient had this abnormality in her sinus MRI and no doctor related it to her prior history of transsphenoidal pituitary resection. In fact, pervious pituitary surgeries, while done transsphenoidally (across the sphenoid sinus), were done sublabial (under the lip). This surgery was done endoscopically or through the nose, and this offered the surgeon visual access to the tumor that may have been hiding there since her first pituitary surgery 20 years prior.

Several other Cushies with persistent Cushing's  have commented since Monday that they too have a "cyst" in their sinus cavity. Many will now ask their neurosurgeons to examine these suspicious areas more closely as possible source of abnormal ACTH cells which cause Cushing's.

****

A case of ectopic pituitary adenoma occurring in the sphenoid sinus

Neurological surgery (2011)

Volume: 39, Issue: 6, Pages: 601-605
Click for full article full article.

Abstract

Ectopic pituitary adenomas are relatively rare tumors. We present a case of ectopic pituitary adenoma occurring in the sphenoid sinus. A 63-year-old woman was referred to our hospital complaining of headache. She had no endocrinological abnormalities. Magnetic resonance imaging showed a tumor in the sphenoid sinus, adjacent to the sellar floor and appearing as a low-signal on T1-weighted image and a high signal on T2-weighted image. No connection between the normal pituitary gland and tumor was observed. Using an endonasal-transsphenoidal approach assisted with neuro-endoscopy, we performed total removal of the tumor. No connection between the normal pituitary gland and the tumor was found. Histopathological analysis showed a pituitary adenoma. As demonstrated by our case report, differential diagnosis of a tumor occurring in the sphenoid sinus must include consideration of the existence of an ectopic pituitary adenoma.

PATIENT STORY: Jennifer S. - My Story

Thank you to the Pituitary Network Association (www.pituitary.org) for sharing patient stories.

https://www.pituitary.org/library/library_detail.aspx?page_id=2566

Jennifer S. - My Story, a Patient Perspective

8/2/2011    Categories:  Women's Health | Inspirational | Patient Perspectives |Featured Articles

It was initially discovered that I had a pituitary tumor in 1992 after a year of strange periods, emotional strife and infections . They did an MRI after my prolactin levels were slightly elevated, I was lactating out of both breasts. Despite the full lactation, they decided that the lab levels indicated nothing much at all, and so my lesion was declared an incidentaloma.  From 1992 until 2000, I had to beg for MRIs or testing as I was told that any problem I had, if any, was thyroid, PCOS, endometriosis or that I had no issue at all - but it was certainly not pituitary.

I went from endocrinologist to endocrinologist. I waited months to see the doctors noted in magazines only to be told that I had no problem at all. I saw all sorts of specialists as I kept getting sick. I saw infectious disease specialists, dermatologist, oncologists, hematologists. My docs were so mystified they kept giving me HIV testing (all negative) and even sent me to a specialist who could not figure it out either. I was not typical in any way - I did not have diabetes, high glucose or high cholesterol or even high blood pressure. But I gained weight fast, had a bleeding disorder, would not heal, got sick very easily, had acne,  had striae (who thought stretch marks were symtptoms!), and a red sweaty face. I was called a liar many times about my diet, exercise and life.

At one point, like many of us pituitary patients, I gave up and stopped seeing doctors. I got worse. The next doctor I saw was a turning point. I gave my list of symptoms and he was the first to say the word "Cushing's". However, he gave up after one urine test but just saying the word was enough that I could do research and realize Cushing's, sadly, fit me perfectly.

At that point I did all I could to educate myself on Cushing's syndrome and testing. I would test barely high at times and then normal. I knew I had the cyclical or episodic form and that most doctors do not acknowledge or treat that form. Finally in 2004, I found a doctor that would treat me and I had surgery a few months later after having some elevated testing. They found that I had two lesions - a 3mm prolactinoma and acth secreting corticotroph hyperplasia.

I had a short period where I was ok, but I never lost my Cushing's, In fact, I got worse. So after 2 years, it was decided to remove my adrenals. They were enlarged and showed bilateral cortical hyperplasia.

Since the removal of my adrenals, I have had both shoulders frozen. I have had significant myopathy, proximal weakness and loss of stamina. I was not able to return to work.  My ACTH which was always normal, rose to over 1000 within a few months of surgery. It is currently near 4000. Since my pathology and my diagnosis is a matter of *dispute* as some doctors cannot accept cyclical patients and/or acth secreting hyperplasia, getting aftercare has been a challenge. Aftercare is not being addressed well by doctors. My next treatment option is radiation with no defined target.

• Be an educated patient. Know the test protocols such as time of test, if ice is needed, medications that mess up testing, etc.
• Whenever possible, get copies of your records and read them. Many times I was told I was normal and I was not.
• Network with other patients to learn.
• Surgical recovery may be a few weeks, hormonal recovery can take years.
• Just because a doctor worked for you, they may or may not work for someone else so best to direct to doctor lists. Opposite is true as well.
• Read reliable information. You may not understand the lingo at first but it does sink in later. Save the links or save the pages to read.
• Everyone's case is different so a best case and worst case may not be you.
• Most people posting on the internet are there because they have problems, Those that do not are out living their lives - which can make you think everyone is having problems - it is not the case.

I Can't Repeat This Enough

Obesity & Cushing's

As I struggle to find sleep again tonight, I happened upon this article in the Los Angeles Times, entitled "Some anti-obesity campaigns may backfire, researchers say."

http://www.latimes.com/news/science/la-sci-obesity-20120912,0,5230176.story

I felt compelled to write the author to give a little information about what it is like to suffer from obesity.

If you are here taking a moment to read this, I thank you, Melissa. Please, please help us. ~m

** ** **

Hello Melissa.

I am obese and I appreciate the sensitivity shown in your recent article. I gained 110 pounds rapidly and unexpectedly despite all efforts to eat well and exercise for many years. I wonder what percentage of this country's obese population may actually have Cushing's. Many otherwise helpful doctors consider Cushing's "impossible to have" so much so that they refuse to test a patient especially when it is the patient who used the internet and available medical literature to research the symptoms online. Many physicians have blamed, scolded, humiliated, and ultimately dismissed my Cushie friends and me when tumors causing a disruption in our endocrine systems are ultimately proven to be the culprits behind our massive weight gain and constellation of bizarre symptoms.

This paragraph, in particular, somewhat explains the prejudice my fellow Cushing's patients face at the hand of those medical professionals we seek out to help us:  

"Even among physicians, obese patients elicit feelings of prejudice and blame. A 2003 survey, published in the journal Obesity Research, found that half considered their obese patients awkward, ugly, unattractive and unlikely to follow their advice. In addition, one-third of doctors viewed obese patients as weak-willed, sloppy and lazy."

On a personal note, I have had two pituitary brain surgeries to remove two separate tumors, yet I am still suffering from persistent Cushing's disease. I hope to have another major surgery within the next few months in another effort to cure myself of Cushing's.

If you are interested in exploring this cause of obesity in greater depth, it would be my honor to sit with you and share more information about Cushing's. An article such as this will spread awareness and undoubtedly help countless people who have suffered for many years undiagnosed from a disease that even the medical community fails to recognize. After all, we Cushies deserve compassion and love despite our illnesses, especially since friends and family fail to support or believe us. We did not do this to ourselves, and we have no control over the damage these tumors do to our bodies. 

Melissa

http://cushingsmoxie.blogspot.com

We are Strong. We are Survivors.

"I am not what happened to me --

I am what I choose to become."

~ Carl Jung

MAGIC & Giving Forward

The big announcement has been made!

The 8th Annual Convention for Adults with Pituitary Disorders will be held in Las Vegas, Nevada from Friday, April 19, 2013 to Sunday, April 21, 2013. Many will arrive on Thursday and leave Sunday or Monday.  Please mark these dates in your calendar and plan to attend, as this will be a wonderfully informative and fulfilling experience as you meet many others with your 'rare' disease.

I posted about the importance of the Magic Foundation on my blog before.

Today, I also wanted to direct you to a place where you can help folks who need a little extra help to cover the expenses to attend the MAGIC Convention. Knowing first hand how much the MAGIC Convention helped her, my dear friend Karen has spearheaded a program to help patients with pituitary disorders join fellow Cushies at next year's MAGIC Foundation's annual convention. I ask you to contribute to the Educational Program Scholarship at giveforward.com for this cause.

*******

Other resources:

• facebook.com/TheMAGICFoundation
• magicfoundation.org
• Cushing's page for the MAGIC Foundation

Feeling Hopeful and Grateful Today

"At times our own light goes out and is rekindled by a spark from another person. Each one of us has cause to think with deep gratitude of those who have lighted the flame within us."

~ Albert Schweitzer (1875-1965), Nobel Laureate

Here we go again...

Getting an MRI on both hips. Hope to rule out osteonecrosis after increasing pain in pelvis and hip joints. Unfortunately, this is so common with Cushing's :/

"Glucocorticoids and Mood"

Another wonderful article from our friends at the Cushing's Support & Research Foundation (www.csrf.net) for this article. It is so important to understand the emotional as well as the physical toll that Cushing's plays.

Click here to read CSRF's article entitled Glucocorticoids and Mood

Glucocorticoids and Mood

By Dr. Jennifer Kirkland, Ph.D On June 20- 21, 2008, I had the rare opportunity to attend the conference Glucocorticoids and Mood: Clinical Manifestations, Risk Factors and Molecular Mechanisms. Sponsored jointly by UC San Diego Department of Psychiatry and The Diana Foundation, this conference came about in part, in response to the death of Diana Padelford Binkley. In 2003, after getting high dose steroids for a herniated disc, Diana suffered the side effect of steroid psychosis and subsequently committed suicide. Since glucocorticoids are used in managing many diseases, the 20% rate of psychiatric impairment found in those getting high dose treatment shows the need for better understanding of the risks and impact on patients. A call for the most recent findings brought researchers from around the world together to unravel the mysteries underlying this phenomenon and to come up with answers to lessen risks on patients. Given that cortisol and its synthetic partner cortisone are used so widely, the impact of high cortisol on mood and memory was highlighted. Since excess cortisol is the cause of Cushing's related symptoms, patients with Cushing's were studied. As many who have had Cushing's already guessed, high rates of mood and memory problems were found. Two-thirds (66%) to 100% of those studied had symptoms ranging from anxiety (66%), impaired concentration (66%), night awakenings (69%), decreased sex drive (74%), impaired memory 83%, irritability (86%), decreased energy (97%), fatigue (100%). High cortisol was found to actually shrink the hippocampus brain region, which related directly to verbal memory problems in Cushing's patients. Luckily, when the high cortisol state is reversed, the brain region goes back to normal size, and memory problems are largely reversed. And with treatment, over time, mood and psychiatric symptoms returned to levels found in those without Cushing's. What a relief to hear in a scientific conference that we aren't crazy, but having Cushing's can make us that way temporarily! The implications of such difficulties have raised awareness of the risks of giving high dose steroids. The types of treatments that tend to trigger mood problems and steroid psychosis were presented. They found that single high dose administrations of corticosteroids can cause temporary irritability, restlessness or memory problems. However, when the treatment is prolonged, steroid psychosis can happen. Studies vary on the rate this happens, but the range is 1.3% to a whopping 57%, making the average across studies 6%. The disturbing part to this finding is that no one knows why one person may have no symptoms and another may commit suicide. Thus, researchers urged that the risk be communicated with a "black box" warning by pharmaceutical companies. The one upside to this problem is that a whole new area of treating psychiatric disorders with cortisol lowering drugs has evolved. Although largely experimental, in some cases, lowering cortisol with mifepristone had a therapeutic effect similar to standard antidepressants making it a potentially good alternative when standard treatment can not be given. The second half of the conference was basic research that studied glucocorticoids on the molecular level. Glucocorticoids (cortisol) exert their effects on individual cells in the body by binding to a protein called a glucocorticoid receptor. Although still in the experimental stages, such research is paving the way for exciting developments. The first of such was the finding that glucocorticoid receptors (GR) can behave differently not just among people but even within a person. Thus, depending on the tissue type, the GR can respond in a highly sensitive or even an immune way. This variability in the action of GR may explain why Cushing's can appear so different in the way it presents clinically. Some people may or may not get the same symptoms in part due to how the GRs respond at the cellular level. Once again, we are finding that Cushing's has many faces, and can not be diagnosed on the basis of having a specific set of symptoms. Researchers have also expanded on the finding that glucocorticoids are the "first-responders" when the body is stressed. The body sends out a red flag that there is a problem by showing markers of inflammation. Glucocorticoids respond by moving in to reduce the inflammation. When studying mood disorders such as depression, a link between having an exaggerated inflammatory response to stress was linked with both depression and illness. Thus, when an individual has a GR that is resistant to this red flag of inflammation, more inflammation occurs. This lack of response is implicated in both cancer risk and depression. Perhaps the most exciting part of this half of the conference was how researchers are working to improve treatments based on basic research findings. Because different GRs behave differently, finding drugs that change behavior at the receptor level could increase the quality of many people's lives. Right now, pharmaceutical researchers are working on this issue in developing a glucocorticoid that does not cause osteoporosis. Thus, for those thousands of people who are on long term, higher dose corticosteroid treatment, within a few years, the new drug could greatly reduce the risk of osteoporosis! Another promising finding will help the many people who suffer with chronically high cortisol levels because of anxiety or depression. The challenge in treating it has been to lower cortisol without completely shutting it down. Even though chronically high cortisol has unpleasant effects, losing the body's ability to respond to stress can be life threatening. Trials of the drug mifepristone have demonstrated that the drug can lower cortisol effects without shutting it down. Thus, those who have chronically high cortisol can get relief without the danger of losing this response that is necessary during stress completely. The final panel discussion revealed that, despite having the best and the brightest researchers in the world present, we were left with more questions than answers. Obviously, the research presented is scratching the surface in finding solutions to complex problems such as Cushing's. But the best part for me though, was to see how the awareness of Cushing's as both a clinical syndrome and model for study has spread worldwide. I was able to look around at the treatment providers in the audience, and say "yeah, I think they get it" when it comes to a compassionate understanding of how devastating Cushing's can be. That was the best realization of all. Editor's Note: Jennifer Kirkland is a clinical neuropsychologist in private practice in the San Francisco Bay Area, California. Dr. Kirkland has the unique combination of years of psychological experience as well as personal experience with Cushing's, which makes her extremely qualified to report on the psychological impact of glucocorticoids.. She counts her two greatest accomplishments as completing her Ph.D. while being diagnosed and treated for adrenal Cushing's and having a baby on 11/30/07.

Solu-Cortef Alert

Thank you to our friends at www.caresfoundation.org for this important reminder. As you know, many Cushies rely on Solu-Cortef in cases of adrenal insufficiency. Solu-Cortef is for Cushies what Glucagon is for Type I diabetics. It is life-saving.

From: CARES Foundation <brendan@caresfoundation.org>

Reminder: Solu-Cortef National Drug Code (NDC) Change Last year Pfizer, the manufacturer of Solu-Cortef®, in the convenient "acto-vials," removed the preservatives from their product, and issued a new NDC number by the FDA. The number is 0009001103.   This NDC number change has apparently continued to make it difficult for pharmacies to find the product in their computer systems, resulting in erroneously informing people that it is no longer available for prescription.   The product is available, but with a new code.   If your pharmacy is having trouble obtaining these products, please instruct them to call Pfizer's Customer Service at 1(800) 533-4535.   Other possible contact numbers for Pfizer are 1(800) 821-7000 or patient services at 1(888) 691-6813.   2414 Morris Ave. Union, NJ, New Jersey 07083 Toll-free: 866-227-3737 Phone: 908-364-0272 www.caresfoundation.org

Hip pain coupled with shoulder pain

 

Next Section

Crutches in Cushing's disease

Avascular necrosis of bone can be almost silent until it comes under unusual strain. We report a case in point and lessons learned.

http://jrsm.rsmjournals.com/content/94/7/348.full

Hip Pain: Another Cushing's Symptom

Cushing's Disease Presenting with Avascular Necrosis of the Hip: An Orthopedic Emergency

ABSTRACT

Nontraumatic avascular necrosis (AVN) of the hip is commonly caused by exogenous glucocorticoid administration, whereas it has rarely been associated with endogenous hypercortisolism. We report a 30-yr-old woman with Cushing's disease whose presenting manifestation was early AVN of the hip. Although plain x-ray was negative, magnetic resonance imaging (MRI) of the hip showed stage 2 AVN. Her orthopedic disease was considered an emergency, and thus, it was treated with core decompression before the diagnosis of Cushing's syndrome (CS) was pursued further. The femur recovered fully, as demonstrated by her improved clinical picture and a subsequent MRI. AVN carries a poor prognosis, if not treated early. The diagnostic procedure of choice is MRI, because plain radiographs are falsely negative in early stages. This case illustrates that AVN can be the presenting manifestation of CS; to prevent irreversible effects on the femoral head, core decompression should not be delayed for the purpose of evaluation and treatment of CS.

Read article in full here:

http://m.jcem.endojournals.org/content/84/9/3010.full#sec-1

Yup, Your Ticker Could Go, Too!!

Cushing's Patients Must Be Screened for Heart Disease

By Piriya Mahendra, MedWire Reporter

Published August 12, 2012

Individuals who use glucocorticoids and exhibit iatrogenic Cushing's syndrome should be "aggressively" targeted for early screening of cardiovascular (CV) risk factors, say researchers.

Laurence Fardet (University College London, UK) and colleagues found that individuals with iatrogenic Cushing's syndrome who were prescribed glucocorticoids had a significantly higher incidence of CV events (including coronary heart disease, heart failure, or ischemic cerebrovascular events) than individuals prescribed glucocorticoids without iatrogenic Cushing's syndrome, or those not prescribed glucocorticoids.

Indeed, Cushing's syndrome patients prescribed glucocorticoids had a CV incidence rate per 100 person-years at risk of 15.1 compared with 6.4 and 4.1 in those without Cushing's but who were prescribed glucocorticoids and those not prescribed glucocorticoids, respectively.

Multivariate analysis revealed that iatrogenic Cushing's patients had a 2.27-fold increased risk for coronary heart disease, a 3.77-fold increased risk for heart failure, and a 2.23-fold increased risk for ischemic cerebrovascular events.

Compared with individuals prescribed glucocorticoids without iatrogenic Cushing's syndrome, those with Cushing's and glucocorticoids had a 2.74-fold increased risk for CV events.

Cushing's patients prescribed glucocorticoids also had a 4.16 higher risk for CV events than individuals not prescribed glucocorticoids.

"These results raise the question of whether glucocorticoids increase the risk of CV events in all patients or only in those who develop iatrogenic Cushing's syndrome," remark the authors.

Iatrogenic Cushing's syndrome is characterized by a cushingoid adiposity, with hypertrophy of adipose tissue in the face (giving the appearance of a "moon face"), dorsocervical region ("buffalo hump," double chin), and abdomen, and thinning of the subcutaneous adipose tissue of the limbs.

The authors say that a glucocorticoid-induced cushingoid appearance must no longer be considered as a minor adverse event of glucocorticoid treatment and point out that it has been associated with some features of the metabolic syndrome.

"It is therefore essential that patients prescribed glucocorticoids who develop iatrogenic Cushing's syndrome are assessed for CV risk and monitored regularly in both primary care and secondary care for early prevention of CV disease," they conclude in the British Medical Journal.

Licensed from Medwire news with permission from Springer Healthcare Ltd. ©Springer Healthcare Ltd. 

http://www.news-medical.net/news/20120807/Cushinge28099s-patients-must-be-screened-for-heart-disease.aspx

All rights reserved. Neither of these parties endorse or recommend any commercial products, services, or equipment.

In Loving Memory: Kym Grupido

Thank you to Boise Glow for Cushing's Awareness for sharing Kym's story as part of their continued efforts to draw attention to this terrible disease.

My heart breaks for Kym, her family, and all those who knew and loved her.

For more about Kym's life and battle with Cushing's, click to read her sister's loving account.

Editor's Note:  While the Cushing's Support & Research Foundation (csrf.net) would like to print only positive stories, many Cushing's stories are very sad.  Kym's story illustrates that even with all our current technology and diagnostics, more awareness is desperately needed.  We hope Kym's story tugs at your heartstrings and will perhaps motivate you to share your own story in a local paper, if you have not done so already.   If Kym's family and doctors had been aware of Cushing's, there is a good chance Kym would not have died.  It is for this reason the CSRF feels strongly that her story needed to be shared.

Click to enlarge.

A Cushie's Life

Pituitary Patient Sues for Misdiagnosis

Pituitary tumors are not as rare as people think. Studies of autopsy reports show that up to 20% of the population -- one in five people -- have a pituitary tumor. However, doctors continue to dismiss patents with acromegaly and Cushing's, causing years of sickness and despair.  One can only hope this court ruling prompts a few MDs study up on pituitary disorders.

For the full story, click through to the BBC website. 

* * * * * * * * * *

From the Pituitary Network Association (www.pituitary.org):

–	Why Is Early Diagnosis Such A Problem? The confusing constellation of symptoms that can be produced by pituitary tumors and the difficult to visualize location make diagnosis very tricky. It is not uncommon for patients to have symptoms of either hormonal deficiency (caused by compression of the pituitary or its "stalk") or hormone excess (caused by unregulated production of hormones by the pituitary tumor). In a significant minority of patients diagnosis is not made until the individual has developed debilitating or life-threatening symptoms of heart disease or adrenal (uncommon), gonadal and/or thyroid insufficiency. Even in the 21st century death from a large pituitary tumor or hormonal deficiency still occurs, albeit rarely. Early diagnosis is usually a reflection of a high index of suspicion on the part of a physician. Unfortunately, many doctors have been taught that pituitary disease is rare, so it is not at the forefront of their list of possible diagnoses.
–	How Prevalent Are Pituitary Tumors/Disease? Autopsy reports and radiologic and MRI evidence from around the globe indicate that one out of every five people worldwide has a pituitary tumor. The earliest study took place in 1936, when Dr. R.T. Costello of the Mayo Foundation conducted a cadaver study and found pituitary tumors in 22.4 % of the population (Costello R.T. Subclinical adenoma of the pituitary gland. Am. J. Pathol. 1936; 12:205-214). Statistics have not changed much ever since. The clinical significance of these findings are critical to determine.
–	Why Are These Tumors So Common? We don't know because funding for benign brain tumor research is virtually nonexistent. That's about to change. In October 2002, Congress passed the Benign Brain Tumor Cancer Registries Amendment Act, which will force hospitals, clinics and doctors to report pituitary tumor incidence rates in the data collection of cancer registries. The problem remains diagnosis. No report of incidence rates is possible without it.

–

Why Aren't Pituitary Tumors/Disease Common Knowledge? There are four main reasons: Pituitary tumors/disease present a vast array of symptoms, and it's often the symptoms that get treated, not the disease. As a result, pituitary patients can spend years being misdiagnosed as their tumors grow. People with undetected pituitary tumors can die of heart attacks, hypothyroidism, adrenal insufficiency or water balance problems, all of which can mask the main cause: a pituitary tumor. Dollars spent. As a result, we have failed to answer the most important question: Why are pituitary tumors so common? There is a lack of education within the medical community and among the general public. The insurance industry hasn't caught on to the untold billions of dollars that could be saved through early diagnosis and treatment. Once it becomes clear that it's in everyone's best interest, the word will spread.

Boom & Bust: Stress Fuels Market Crisis

As a blogger and patient advocate, I always strive to explain the Cushing's experience in a way that caregivers, family and friends will understand. My hope has always been that if they really understood the damage we face, perhaps our support system would encircle us and protect us as we walk a very difficult road to remission. This does not happen as often as it should, despite nearly four years of blogging, but I am hard-headed. So, I keep trying.

To that end, I am thrilled to share this article, "Boom & Bust: Stress fuels market crisis." This article provides  fascinatingly detailed look at the roles stress and cortisol played during the financial crisis. Cortisol is cited for changing the bodies and personalities of risk-seeking stockbrokers as they faced an uncertain market future. 

The author even names cortisol "the molecule of irrational pessimism." 

I hope you will take a few moments to read this article, and please understand that the changes these brokers faced during the crisis are the same struggles we Cushing's patients face every day, for years and years. While I am not asking for empathy for stockbrokers, per se, I am asking you to read this article with Cushies in place of the stockbrokers. Reading about their symptoms may help you see your Cushie in a new way. If it does, hold her or him a little tighter, and admit you learned something about this illness. Your stock is sure to rise, as it will be music to your loved one's ears. 

Click through to the original article on the Montreal Gazette.